Clinical Trials
4 trialsNCT02400242 2024-07-09
Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma
Celgene
Phase 1 Terminated
NCT02635061 2024-05-07
Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer
Celgene
Phase 1 Terminated
NCT02551185 2020-02-26
ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Celgene
Phase 1 Completed
NCT02935790 2017-08-24
Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab
Celgene
Phase 1 Completed